Published in Bioorg Med Chem Lett on April 21, 2011
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell (2007) 7.74
Complications associated with single-level transforaminal lumbar interbody fusion. Spine J (2009) 2.99
VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol (2004) 2.56
Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial. J Clin Oncol (2006) 2.48
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood (2005) 2.41
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol (2008) 2.11
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer. J Natl Cancer Inst (2004) 2.06
The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. Proc Natl Acad Sci U S A (2004) 2.05
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. Blood (2010) 1.83
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood (2012) 1.77
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. Cancer Cell (2013) 1.74
Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796. Antimicrob Agents Chemother (2008) 1.57
Biomechanical evaluation and comparison of polyetheretherketone rod system to traditional titanium rod fixation. Spine J (2008) 1.52
Thromboprophylaxis in spinal trauma surgery: consensus among spine trauma surgeons. Spine J (2009) 1.46
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models. Mol Cancer Ther (2014) 1.42
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery. J Med Chem (2008) 1.32
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chem Neurosci (2011) 1.30
BET bromodomain inhibitors: a patent review. Expert Opin Ther Pat (2013) 1.29
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies. J Med Chem (2014) 1.27
Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J Biol Chem (2011) 1.25
Discovery of small molecule c-Met inhibitors: Evolution and profiles of clinical candidates. Anticancer Agents Med Chem (2010) 1.16
Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor. Antimicrob Agents Chemother (2006) 1.14
PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation. J Biol Chem (2010) 1.14
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors. J Med Chem (2007) 1.13
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. Br J Haematol (2006) 1.13
A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma. Clin Cancer Res (2009) 1.09
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cells. Clin Cancer Res (2013) 1.06
Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer. Cancer (2010) 1.03
Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J Leukoc Biol (2008) 1.02
A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations. FASEB J (2006) 1.01
Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa. Eur J Cancer (2005) 1.00
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma. Cancer (2003) 1.00
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase. Antimicrob Agents Chemother (2004) 0.97
Knowledge-based chemoinformatic approaches to drug discovery. Drug Discov Today (2006) 0.96
A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy. Clin Colorectal Cancer (2010) 0.94
A look at an interactive classroom-based drug abuse prevention program: interactive contents and suggestions for research. J Drug Educ (2003) 0.94
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer (2014) 0.91
Cell-based treatments for diabetes. Drug Discov Today (2008) 0.91
Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4. Bioorg Med Chem Lett (2006) 0.91
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation. Proc Natl Acad Sci U S A (2014) 0.91
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients. Br J Haematol (2011) 0.89
Regulation of ubiquitin transfer by XIAP, a dimeric RING E3 ligase. Biochem J (2013) 0.89
The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis. Eur Spine J (2009) 0.89
Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s). J Virol (2004) 0.88
Prehospital interventions performed in a combat zone: a prospective multicenter study of 1,003 combat wounded. J Trauma Acute Care Surg (2012) 0.85
A role for the extracellular calcium-sensing receptor in cell-cell communication in pancreatic islets of langerhans. Cell Physiol Biochem (2008) 0.84
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. Clin Breast Cancer (2002) 0.84
Radical [3 + 2]-annulation of divinylcyclopropanes: rapid synthesis of complex meloscine analogs. Org Lett (2013) 0.84
Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg (2009) 0.83
A tethered bilayer sensor containing alamethicin channels and its detection of amiloride based inhibitors. Biosens Bioelectron (2003) 0.83
Energy drink-related supraventricular tachycardia. Am J Med (2008) 0.83
Complications and Unfavorable Clinical Outcomes in Obese and Overweight Patients Treated for Adult Lumbar or Thoracolumbar Scoliosis With Combined Anterior/Posterior Surgery. J Spinal Disord Tech (2015) 0.82
Wound healing trajectories in burn patients and their impact on mortality. J Burn Care Res (2014) 0.82
Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model. Acad Radiol (2009) 0.82
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists. J Med Chem (2006) 0.82
Text-mining approach to evaluate terms for ontology development. J Biomed Inform (2009) 0.82
Prevalence and impact of late defecation in the critically ill, thermally injured adult patient. J Burn Care Res (2014) 0.82
The role of cytosolic phospholipase A(2) in insulin secretion. Diabetes (2004) 0.81
A laparoscopic swine model of noncompressible torso hemorrhage. J Trauma Acute Care Surg (2014) 0.81
Weekly paclitaxel in women age 65 and above with metastatic breast cancer. Breast Cancer Res Treat (2002) 0.80
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem Lett (2010) 0.80
Design, expression, and purification of a Flaviviridae polymerase using a high-throughput approach to facilitate crystal structure determination. Protein Sci (2004) 0.80
Preclinical evaluation of radiosensitizing activity of Pluronic block copolymers. Int J Radiat Biol (2013) 0.79
The management and outcome of spinal implant-related infections in pediatric patients: a retrospective review. Pediatr Infect Dis J (2014) 0.79
Importance of quantitative analysis in the generation of insulin-expressing cells from human embryonic stem cells. Pancreas (2010) 0.79
Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen. Eur J Haematol (2009) 0.79
Percutaneous vertebral compression fracture management with polyethylene mesh-contained morcelized allograft bone. Curr Rev Musculoskelet Med (2008) 0.79
Human insulin fibril-assisted synthesis of fluorescent gold nanoclusters in alkaline media under physiological temperature. Colloids Surf B Biointerfaces (2013) 0.78
Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method. Ther Drug Monit (2011) 0.78
Operation versus antibiotics--The "appendicitis conundrum" continues: A meta-analysis. J Trauma Acute Care Surg (2017) 0.77
2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilines. Bioorg Med Chem Lett (2010) 0.77
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers. Cancer Chemother Pharmacol (2015) 0.77
Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary. FEMS Immunol Med Microbiol (2005) 0.77
Simplified silvestrol analogues with potent cytotoxic activity. ChemMedChem (2014) 0.77
Solid/solution-phase annulation reagents: single-step synthesis of cyclic amine derivatives. Angew Chem Int Ed Engl (2005) 0.77
Surface chemistry and spectroscopy of human insulin Langmuir monolayer. J Phys Chem B (2012) 0.77
Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue. Org Biomol Chem (2012) 0.77
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. Cancer Cell (2016) 0.77
The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity. ChemMedChem (2008) 0.76